Flagship Ventures Fund IV-Rx, L.P.
Insider CIK 1590973 · EBIO 10% owner · SYRS 10% owner · MCRB 10% owner · AXLA 10% owner · EDIT 10% owner · MRNA 10% owner · EVLO 10% owner · RUBY 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| EVLO Evelo Biosciences, Inc. | P Buy | 2022-05-27 | 2022-06-01 | 4,383,561 | $1.46 | $6.40M | 7,590,873 | SEC↗ |
| EVLO Evelo Biosciences, Inc. | P Buy | 2022-05-27 | 2022-06-01 | 13,698,630 | $1.46 | $20.00M | 13,698,630 | SEC↗ |
| EVLO Evelo Biosciences, Inc. | P Buy | 2022-05-27 | 2022-06-01 | 1,369,863 | $1.46 | $2.00M | 5,495,324 | SEC↗ |
| EVLO Evelo Biosciences, Inc. | P Buy | 2022-05-27 | 2022-06-01 | 1,095,890 | $1.46 | $1.60M | 1,887,419 | SEC↗ |
| EVLO Evelo Biosciences, Inc. | P Buy | 2022-05-27 | 2022-06-01 | 6,849,315 | $1.46 | $10.00M | 8,219,791 | SEC↗ |
| AXLA Axcella Health Inc. | P Buy | 2022-03-16 | 2022-03-18 | 947,905 | $1.91 | $1.81M | 2,004,657 | SEC↗ |
| AXLA Axcella Health Inc. | P Buy | 2022-03-16 | 2022-03-18 | 3,791,623 | $1.91 | $7.24M | 8,600,403 | SEC↗ |
| AXLA Axcella Health Inc. | P Buy | 2022-03-16 | 2022-03-18 | 1,579,843 | $1.91 | $3.02M | 4,465,866 | SEC↗ |
| EVLO Evelo Biosciences, Inc. | P Buy | 2021-02-02 | 2021-02-04 | 37,143 | $15.00 | $557.1K | 1,370,476 | SEC↗ |
| EVLO Evelo Biosciences, Inc. | P Buy | 2021-02-02 | 2021-02-04 | 46,429 | $15.00 | $696.4K | 4,125,461 | SEC↗ |
| EVLO Evelo Biosciences, Inc. | P Buy | 2021-02-02 | 2021-02-04 | 37,143 | $15.00 | $557.1K | 3,207,312 | SEC↗ |
| EVLO Evelo Biosciences, Inc. | P Buy | 2021-02-02 | 2021-02-04 | 9,285 | $15.00 | $139.3K | 791,529 | SEC↗ |
| MCRB Seres Therapeutics, Inc. | J Other | 2020-11-23 | 2020-11-25 | 3,587,820 | — | $0 | 4,434,600 | SEC↗ |
| MCRB Seres Therapeutics, Inc. | J Other | 2020-11-23 | 2020-11-25 | 642,180 | — | $0 | 1,283,282 | SEC↗ |
| MCRB Seres Therapeutics, Inc. | J Other | 2020-11-23 | 2020-11-25 | 966,234 | — | $0 | 0 | SEC↗ |
| MCRB Seres Therapeutics, Inc. | J Other | 2020-11-23 | 2020-11-25 | 1,186,310 | — | $0 | 3,258,134 | SEC↗ |
| MCRB Seres Therapeutics, Inc. | J Other | 2020-11-23 | 2020-11-25 | 1,481,481 | — | $0 | 2,962,963 | SEC↗ |
| MCRB Seres Therapeutics, Inc. | J Other | 2020-11-23 | 2020-11-25 | 43,154 | — | $0 | 0 | SEC↗ |
| MRNA Moderna, Inc. | J Other | 2020-08-17 | 2020-08-19 | 7,550,810 | — | $0 | 14,435,589 | SEC↗ |
| MRNA Moderna, Inc. | J Other | 2020-08-17 | 2020-08-19 | 2,053,049 | — | $0 | 0 | SEC↗ |
| MRNA Moderna, Inc. | J Other | 2020-08-17 | 2020-08-19 | 1,449,190 | — | $0 | 4,971,576 | SEC↗ |
| EVLO Evelo Biosciences, Inc. | P Buy | 2020-06-29 | 2020-07-01 | 1,666,667 | $3.75 | $6.25M | 4,079,032 | SEC↗ |
| EVLO Evelo Biosciences, Inc. | P Buy | 2020-06-29 | 2020-07-01 | 1,333,333 | $3.75 | $5.00M | 1,333,333 | SEC↗ |
| EVLO Evelo Biosciences, Inc. | P Buy | 2020-06-29 | 2020-07-01 | 333,333 | $3.75 | $1.25M | 782,244 | SEC↗ |
| EVLO Evelo Biosciences, Inc. | P Buy | 2020-06-29 | 2020-07-01 | 1,333,333 | $3.75 | $5.00M | 3,170,169 | SEC↗ |
| MRNA Moderna, Inc. | S Sale | 2020-05-22 | 2020-05-26 | 363,594 | $69.45 | $25.25M | 22,042,805 | SEC↗ |
| MRNA Moderna, Inc. | S Sale | 2020-05-22 | 2020-05-26 | 56,406 | $70.18 | $3.96M | 21,986,399 | SEC↗ |
| MRNA Moderna, Inc. | S Sale | 2020-05-22 | 2020-05-26 | 69,254 | $69.45 | $4.81M | 6,431,512 | SEC↗ |
| MRNA Moderna, Inc. | S Sale | 2020-05-22 | 2020-05-26 | 10,746 | $70.18 | $754.2K | 6,420,766 | SEC↗ |
| MRNA Moderna, Inc. | S Sale | 2020-05-21 | 2020-05-26 | 7,443 | $68.81 | $512.2K | 6,507,584 | SEC↗ |
| MRNA Moderna, Inc. | S Sale | 2020-05-21 | 2020-05-26 | 1,933 | $72.44 | $140.0K | 22,406,399 | SEC↗ |
| MRNA Moderna, Inc. | S Sale | 2020-05-21 | 2020-05-26 | 42,540 | $65.77 | $2.80M | 6,538,226 | SEC↗ |
| MRNA Moderna, Inc. | S Sale | 2020-05-21 | 2020-05-26 | 23,199 | $67.15 | $1.56M | 6,515,027 | SEC↗ |
| MRNA Moderna, Inc. | S Sale | 2020-05-21 | 2020-05-26 | 3,900 | $70.46 | $274.8K | 6,503,684 | SEC↗ |
| MRNA Moderna, Inc. | S Sale | 2020-05-21 | 2020-05-26 | 2,551 | $71.51 | $182.4K | 6,501,133 | SEC↗ |
| MRNA Moderna, Inc. | S Sale | 2020-05-21 | 2020-05-26 | 367 | $72.44 | $26.6K | 6,500,766 | SEC↗ |
| MRNA Moderna, Inc. | S Sale | 2020-05-21 | 2020-05-26 | 223,314 | $65.77 | $14.69M | 22,603,085 | SEC↗ |
| MRNA Moderna, Inc. | S Sale | 2020-05-21 | 2020-05-26 | 121,771 | $67.15 | $8.18M | 22,481,314 | SEC↗ |
| MRNA Moderna, Inc. | S Sale | 2020-05-21 | 2020-05-26 | 39,082 | $68.81 | $2.69M | 22,442,232 | SEC↗ |
| MRNA Moderna, Inc. | S Sale | 2020-05-21 | 2020-05-26 | 20,492 | $70.46 | $1.44M | 22,421,740 | SEC↗ |
| MRNA Moderna, Inc. | S Sale | 2020-05-21 | 2020-05-26 | 13,408 | $71.51 | $958.8K | 22,408,332 | SEC↗ |
| AXLA Axcella Health Inc. | P Buy | 2020-05-18 | 2020-05-20 | 380,000 | $4.75 | $1.80M | 1,056,752 | SEC↗ |
| AXLA Axcella Health Inc. | P Buy | 2020-05-18 | 2020-05-20 | 1,900,000 | $4.75 | $9.03M | 2,886,023 | SEC↗ |
| AXLA Axcella Health Inc. | P Buy | 2020-05-18 | 2020-05-20 | 1,520,000 | $4.75 | $7.22M | 4,808,780 | SEC↗ |
| MRNA Moderna, Inc. | J Other | 2020-05-11 | 2020-05-13 | 8,390,000 | — | $0 | 22,826,399 | SEC↗ |
| MRNA Moderna, Inc. | J Other | 2020-05-11 | 2020-05-13 | 2,281,179 | — | $0 | 0 | SEC↗ |
| MRNA Moderna, Inc. | J Other | 2020-05-11 | 2020-05-13 | 1,610,000 | — | $0 | 6,580,766 | SEC↗ |
| MRNA Moderna, Inc. | S Sale | 2019-12-11 | 2019-12-11 | 199,935 | $18.65 | $3.73M | 31,216,399 | SEC↗ |
| MRNA Moderna, Inc. | S Sale | 2019-12-11 | 2019-12-11 | 38,366 | $18.65 | $715.5K | 8,190,766 | SEC↗ |
| MRNA Moderna, Inc. | S Sale | 2019-12-10 | 2019-12-11 | 4,092 | $18.96 | $77.6K | 8,229,132 | SEC↗ |
| MRNA Moderna, Inc. | S Sale | 2019-12-10 | 2019-12-11 | 21,325 | $18.96 | $404.3K | 31,416,334 | SEC↗ |
| MRNA Moderna, Inc. | S Sale | 2019-12-09 | 2019-12-11 | 27,714 | $18.99 | $526.3K | 8,233,224 | SEC↗ |
| MRNA Moderna, Inc. | S Sale | 2019-12-09 | 2019-12-11 | 144,423 | $18.99 | $2.74M | 31,437,659 | SEC↗ |
| MRNA Moderna, Inc. | J Other | 2019-12-09 | 2019-12-11 | 1,735,720 | — | $0 | 0 | SEC↗ |
| MRNA Moderna, Inc. | J Other | 2019-12-09 | 2019-12-11 | 1,207,658 | — | $0 | 8,260,938 | SEC↗ |
| MRNA Moderna, Inc. | J Other | 2019-12-09 | 2019-12-11 | 6,292,342 | — | $0 | 31,582,082 | SEC↗ |
| AXLA Axcella Health Inc. | C Conversion deriv | 2019-05-13 | 2019-05-15 | 895,255 | — | $0 | 0 | SEC↗ |
| AXLA Axcella Health Inc. | C Conversion deriv | 2019-05-13 | 2019-05-15 | 89,525 | — | $0 | 0 | SEC↗ |
| AXLA Axcella Health Inc. | C Conversion deriv | 2019-05-13 | 2019-05-15 | 358,102 | — | $0 | 0 | SEC↗ |
| AXLA Axcella Health Inc. | C Conversion deriv | 2019-05-13 | 2019-05-15 | 151,643 | — | $0 | 0 | SEC↗ |
| AXLA Axcella Health Inc. | C Conversion deriv | 2019-05-13 | 2019-05-15 | 617,914 | — | $0 | 0 | SEC↗ |
| AXLA Axcella Health Inc. | C Conversion deriv | 2019-05-13 | 2019-05-15 | 222,506 | — | $0 | 0 | SEC↗ |
| AXLA Axcella Health Inc. | C Conversion deriv | 2019-05-13 | 2019-05-15 | 1,005,413 | — | $0 | 0 | SEC↗ |
| AXLA Axcella Health Inc. | C Conversion deriv | 2019-05-13 | 2019-05-15 | 1,384,615 | — | $0 | 0 | SEC↗ |
| AXLA Axcella Health Inc. | C Conversion deriv | 2019-05-13 | 2019-05-15 | 4,153,847 | — | $0 | 0 | SEC↗ |
| AXLA Axcella Health Inc. | C Conversion deriv | 2019-05-13 | 2019-05-15 | 928,074 | — | $0 | 0 | SEC↗ |
| AXLA Axcella Health Inc. | C Conversion deriv | 2019-05-13 | 2019-05-15 | 386,697 | — | $0 | 0 | SEC↗ |
| AXLA Axcella Health Inc. | C Conversion | 2019-05-13 | 2019-05-15 | 751,691 | — | $0 | 1,430,301 | SEC↗ |
| AXLA Axcella Health Inc. | P Buy | 2019-05-13 | 2019-05-15 | 500,000 | $20.00 | $10.00M | 986,023 | SEC↗ |
| AXLA Axcella Health Inc. | C Conversion | 2019-05-13 | 2019-05-15 | 486,023 | — | $0 | 486,023 | SEC↗ |
| AXLA Axcella Health Inc. | C Conversion | 2019-05-13 | 2019-05-15 | 48,602 | — | $0 | 676,752 | SEC↗ |
| AXLA Axcella Health Inc. | C Conversion | 2019-05-13 | 2019-05-15 | 194,409 | — | $0 | 3,288,780 | SEC↗ |
| AXLA Axcella Health Inc. | C Conversion | 2019-05-13 | 2019-05-15 | 82,324 | — | $0 | 628,150 | SEC↗ |
| AXLA Axcella Health Inc. | C Conversion | 2019-05-13 | 2019-05-15 | 335,457 | — | $0 | 3,094,371 | SEC↗ |
| AXLA Axcella Health Inc. | C Conversion | 2019-05-13 | 2019-05-15 | 120,795 | — | $0 | 1,761,029 | SEC↗ |
| AXLA Axcella Health Inc. | C Conversion | 2019-05-13 | 2019-05-15 | 2,255,074 | — | $0 | 2,255,074 | SEC↗ |
| AXLA Axcella Health Inc. | C Conversion | 2019-05-13 | 2019-05-15 | 503,840 | — | $0 | 2,758,914 | SEC↗ |
| AXLA Axcella Health Inc. | C Conversion | 2019-05-13 | 2019-05-15 | 209,933 | — | $0 | 1,640,234 | SEC↗ |
| AXLA Axcella Health Inc. | C Conversion | 2019-05-13 | 2019-05-15 | 545,826 | — | $0 | 545,826 | SEC↗ |
| MRNA Moderna, Inc. | C Conversion deriv | 2018-12-11 | 2018-12-13 | 1,428,432 | — | $0 | 0 | SEC↗ |
| MRNA Moderna, Inc. | C Conversion deriv | 2018-12-11 | 2018-12-13 | 5,713,739 | — | $0 | 0 | SEC↗ |
| MRNA Moderna, Inc. | C Conversion deriv | 2018-12-11 | 2018-12-13 | 6,195,632 | — | $0 | 0 | SEC↗ |
| MRNA Moderna, Inc. | C Conversion deriv | 2018-12-11 | 2018-12-13 | 24,782,551 | — | $0 | 0 | SEC↗ |
| MRNA Moderna, Inc. | C Conversion deriv | 2018-12-11 | 2018-12-13 | 1,823,036 | — | $0 | 0 | SEC↗ |
| MRNA Moderna, Inc. | C Conversion deriv | 2018-12-11 | 2018-12-13 | 7,292,145 | — | $0 | 0 | SEC↗ |
| MRNA Moderna, Inc. | C Conversion deriv | 2018-12-11 | 2018-12-13 | 21,496 | — | $0 | 0 | SEC↗ |
| MRNA Moderna, Inc. | C Conversion deriv | 2018-12-11 | 2018-12-13 | 85,989 | — | $0 | 0 | SEC↗ |
| MRNA Moderna, Inc. | C Conversion | 2018-12-11 | 2018-12-13 | 6,195,632 | — | $0 | 8,018,668 | SEC↗ |
| MRNA Moderna, Inc. | C Conversion | 2018-12-11 | 2018-12-13 | 24,782,551 | — | $0 | 32,074,696 | SEC↗ |
| MRNA Moderna, Inc. | C Conversion | 2018-12-11 | 2018-12-13 | 5,713,739 | — | $0 | 37,788,435 | SEC↗ |
| MRNA Moderna, Inc. | C Conversion | 2018-12-11 | 2018-12-13 | 1,428,432 | — | $0 | 9,447,100 | SEC↗ |
| MRNA Moderna, Inc. | C Conversion | 2018-12-11 | 2018-12-13 | 7,292,145 | — | $0 | 7,292,145 | SEC↗ |
| MRNA Moderna, Inc. | C Conversion | 2018-12-11 | 2018-12-13 | 1,823,036 | — | $0 | 1,823,036 | SEC↗ |
| MRNA Moderna, Inc. | C Conversion | 2018-12-11 | 2018-12-13 | 21,496 | — | $0 | 9,468,596 | SEC↗ |
| MRNA Moderna, Inc. | C Conversion | 2018-12-11 | 2018-12-13 | 85,989 | — | $0 | 37,874,424 | SEC↗ |
| RUBY Rubius Therapeutics, Inc. | C Conversion deriv | 2018-07-20 | 2018-07-23 | 1,781,843 | — | $0 | 0 | SEC↗ |
| RUBY Rubius Therapeutics, Inc. | C Conversion deriv | 2018-07-20 | 2018-07-23 | 195,466 | — | $0 | 0 | SEC↗ |
| RUBY Rubius Therapeutics, Inc. | C Conversion deriv | 2018-07-20 | 2018-07-23 | 195,466 | — | $0 | 0 | SEC↗ |
| RUBY Rubius Therapeutics, Inc. | C Conversion deriv | 2018-07-20 | 2018-07-23 | 781,860 | — | $0 | 0 | SEC↗ |
| RUBY Rubius Therapeutics, Inc. | C Conversion deriv | 2018-07-20 | 2018-07-23 | 15,323,593 | — | $0 | 0 | SEC↗ |
| RUBY Rubius Therapeutics, Inc. | C Conversion deriv | 2018-07-20 | 2018-07-23 | 3,830,402 | — | $0 | 0 | SEC↗ |
| RUBY Rubius Therapeutics, Inc. | C Conversion deriv | 2018-07-20 | 2018-07-23 | 5,000,000 | — | $0 | 0 | SEC↗ |
| RUBY Rubius Therapeutics, Inc. | C Conversion deriv | 2018-07-20 | 2018-07-23 | 5,000,000 | — | $0 | 0 | SEC↗ |
| RUBY Rubius Therapeutics, Inc. | C Conversion deriv | 2018-07-20 | 2018-07-23 | 593,948 | — | $0 | 0 | SEC↗ |
| RUBY Rubius Therapeutics, Inc. | C Conversion deriv | 2018-07-20 | 2018-07-23 | 593,948 | — | $0 | 0 | SEC↗ |
| RUBY Rubius Therapeutics, Inc. | C Conversion | 2018-07-20 | 2018-07-23 | 195,466 | — | $0 | 5,789,414 | SEC↗ |
| RUBY Rubius Therapeutics, Inc. | C Conversion | 2018-07-20 | 2018-07-23 | 5,000,000 | — | $0 | 5,000,000 | SEC↗ |
| RUBY Rubius Therapeutics, Inc. | C Conversion | 2018-07-20 | 2018-07-23 | 3,830,402 | — | $0 | 3,830,402 | SEC↗ |
| RUBY Rubius Therapeutics, Inc. | C Conversion | 2018-07-20 | 2018-07-23 | 15,323,593 | — | $0 | 15,323,593 | SEC↗ |
| RUBY Rubius Therapeutics, Inc. | C Conversion | 2018-07-20 | 2018-07-23 | 781,860 | — | $0 | 2,563,703 | SEC↗ |
| RUBY Rubius Therapeutics, Inc. | C Conversion | 2018-07-20 | 2018-07-23 | 195,466 | — | $0 | 5,789,414 | SEC↗ |
| RUBY Rubius Therapeutics, Inc. | C Conversion | 2018-07-20 | 2018-07-23 | 1,781,843 | — | $0 | 1,781,843 | SEC↗ |
| RUBY Rubius Therapeutics, Inc. | C Conversion | 2018-07-20 | 2018-07-23 | 593,948 | — | $0 | 5,593,948 | SEC↗ |
| RUBY Rubius Therapeutics, Inc. | C Conversion | 2018-07-20 | 2018-07-23 | 593,948 | — | $0 | 5,593,948 | SEC↗ |
| RUBY Rubius Therapeutics, Inc. | C Conversion | 2018-07-20 | 2018-07-23 | 5,000,000 | — | $0 | 5,000,000 | SEC↗ |
| EVLO Evelo Biosciences, Inc. | C Conversion deriv | 2018-05-11 | 2018-05-15 | 4,643,963 | — | $0 | 0 | SEC↗ |
| EVLO Evelo Biosciences, Inc. | C Conversion deriv | 2018-05-11 | 2018-05-15 | 18,611,110 | — | $0 | 0 | SEC↗ |
| EVLO Evelo Biosciences, Inc. | C Conversion deriv | 2018-05-11 | 2018-05-15 | 8,333,000 | — | $0 | 0 | SEC↗ |
| EVLO Evelo Biosciences, Inc. | C Conversion deriv | 2018-05-11 | 2018-05-15 | 5,416,667 | — | $0 | 0 | SEC↗ |
| EVLO Evelo Biosciences, Inc. | C Conversion deriv | 2018-05-11 | 2018-05-15 | 10,102,055 | — | $0 | 0 | SEC↗ |
| EVLO Evelo Biosciences, Inc. | C Conversion deriv | 2018-05-11 | 2018-05-15 | 12,536,945 | — | $0 | 0 | SEC↗ |
| EVLO Evelo Biosciences, Inc. | P Buy | 2018-05-11 | 2018-05-15 | 281,250 | $16.00 | $4.50M | 18,233,403 | SEC↗ |
| EVLO Evelo Biosciences, Inc. | C Conversion | 2018-05-11 | 2018-05-15 | 14,622,143 | — | $0 | 17,952,153 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | J Other | 2017-08-17 | 2017-08-21 | 1,295,997 | — | $0 | 2,378,663 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | J Other | 2017-08-17 | 2017-08-21 | 306,222 | — | $0 | 612,442 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | J Other | 2017-08-17 | 2017-08-21 | 54,293 | — | $0 | 0 | SEC↗ |
| EBIO Eleven Biotherapeutics, In | S Sale | 2016-09-23 | 2016-09-26 | 41,178 | $3.10 | $127.7K | 426,885 | SEC↗ |
| EBIO Eleven Biotherapeutics, In | S Sale | 2016-09-23 | 2016-09-26 | 3,118 | $3.16 | $9.9K | 117,080 | SEC↗ |
| EBIO Eleven Biotherapeutics, In | S Sale | 2016-09-23 | 2016-09-26 | 12,482 | $3.16 | $39.4K | 468,063 | SEC↗ |
| EBIO Eleven Biotherapeutics, In | S Sale | 2016-09-23 | 2016-09-26 | 10,293 | $3.10 | $31.9K | 106,787 | SEC↗ |
| EBIO Eleven Biotherapeutics, In | S Sale | 2016-09-22 | 2016-09-26 | 188,367 | $3.17 | $597.1K | 480,545 | SEC↗ |
| EBIO Eleven Biotherapeutics, In | S Sale | 2016-09-22 | 2016-09-26 | 47,090 | $3.17 | $149.3K | 120,198 | SEC↗ |
| EBIO Eleven Biotherapeutics, In | S Sale | 2016-09-22 | 2016-09-26 | 28,163 | $3.18 | $89.6K | 167,288 | SEC↗ |
| EBIO Eleven Biotherapeutics, In | S Sale | 2016-09-22 | 2016-09-26 | 112,731 | $3.18 | $358.5K | 668,912 | SEC↗ |
| EBIO Eleven Biotherapeutics, In | S Sale | 2016-09-21 | 2016-09-21 | 258,214 | $3.75 | $968.3K | 781,643 | SEC↗ |
| EBIO Eleven Biotherapeutics, In | S Sale | 2016-09-21 | 2016-09-21 | 64,509 | $3.75 | $241.9K | 195,451 | SEC↗ |
| EBIO Eleven Biotherapeutics, In | S Sale | 2016-09-20 | 2016-09-21 | 10,778 | $3.39 | $36.5K | 259,960 | SEC↗ |
| EBIO Eleven Biotherapeutics, In | S Sale | 2016-09-20 | 2016-09-21 | 43,139 | $3.39 | $146.2K | 1,039,857 | SEC↗ |
| EBIO Eleven Biotherapeutics, In | S Sale | 2016-09-19 | 2016-09-21 | 1,939 | $3.31 | $6.4K | 270,738 | SEC↗ |
| EBIO Eleven Biotherapeutics, In | S Sale | 2016-09-19 | 2016-09-21 | 7,761 | $3.31 | $25.7K | 1,082,996 | SEC↗ |
| EBIO Eleven Biotherapeutics, In | S Sale | 2016-09-15 | 2016-09-16 | 536 | $4.16 | $2.2K | 272,677 | SEC↗ |
| EBIO Eleven Biotherapeutics, In | S Sale | 2016-09-15 | 2016-09-16 | 2,145 | $4.16 | $8.9K | 1,090,757 | SEC↗ |
| EBIO Eleven Biotherapeutics, In | S Sale | 2016-09-14 | 2016-09-16 | 8,802 | $4.18 | $36.8K | 273,213 | SEC↗ |
| EBIO Eleven Biotherapeutics, In | S Sale | 2016-09-14 | 2016-09-16 | 35,209 | $4.18 | $147.2K | 1,092,902 | SEC↗ |
| EBIO Eleven Biotherapeutics, In | S Sale | 2016-09-07 | 2016-09-08 | 32,597 | $4.51 | $147.0K | 1,128,111 | SEC↗ |
| EBIO Eleven Biotherapeutics, In | S Sale | 2016-09-07 | 2016-09-08 | 8,145 | $4.51 | $36.7K | 282,015 | SEC↗ |
| EBIO Eleven Biotherapeutics, In | S Sale | 2016-09-07 | 2016-09-08 | 52,985 | $4.51 | $239.0K | 1,833,802 | SEC↗ |
| EBIO Eleven Biotherapeutics, In | S Sale | 2016-09-06 | 2016-09-08 | 12,441 | $4.63 | $57.6K | 1,160,708 | SEC↗ |
| EBIO Eleven Biotherapeutics, In | S Sale | 2016-09-06 | 2016-09-08 | 20,221 | $4.63 | $93.6K | 1,886,787 | SEC↗ |
| EBIO Eleven Biotherapeutics, In | S Sale | 2016-09-06 | 2016-09-08 | 3,108 | $4.63 | $14.4K | 290,160 | SEC↗ |
| EDIT Editas Medicine, Inc. | J Other | 2016-08-11 | 2016-08-15 | 50,271 | — | $0 | 0 | SEC↗ |
| EDIT Editas Medicine, Inc. | J Other | 2016-08-11 | 2016-08-15 | 1,200,000 | — | $0 | 2,764,256 | SEC↗ |
| EDIT Editas Medicine, Inc. | J Other | 2016-08-11 | 2016-08-15 | 300,000 | — | $0 | 691,060 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | C Conversion deriv | 2016-07-06 | 2016-07-07 | 800,000 | — | $0 | 0 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | C Conversion deriv | 2016-07-06 | 2016-07-07 | 6,000,000 | — | $0 | 0 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | C Conversion deriv | 2016-07-06 | 2016-07-07 | 1,500,000 | — | $0 | 0 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | C Conversion deriv | 2016-07-06 | 2016-07-07 | 1,779,981 | — | $0 | 0 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | C Conversion deriv | 2016-07-06 | 2016-07-07 | 444,995 | — | $0 | 0 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | C Conversion deriv | 2016-07-06 | 2016-07-07 | 200,000 | — | $0 | 0 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | C Conversion deriv | 2016-07-06 | 2016-07-07 | 4,000,000 | — | $0 | 0 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | C Conversion deriv | 2016-07-06 | 2016-07-07 | 1,000,000 | — | $0 | 0 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | C Conversion | 2016-07-06 | 2016-07-07 | 53,333 | — | $0 | 53,333 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | C Conversion | 2016-07-06 | 2016-07-07 | 474,661 | — | $0 | 3,354,660 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | P Buy | 2016-07-06 | 2016-07-07 | 320,000 | $12.50 | $4.00M | 3,674,660 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | P Buy | 2016-07-06 | 2016-07-07 | 80,000 | $12.50 | $1.00M | 918,664 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | C Conversion | 2016-07-06 | 2016-07-07 | 213,333 | — | $0 | 213,333 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | C Conversion | 2016-07-06 | 2016-07-07 | 118,665 | — | $0 | 838,664 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | C Conversion | 2016-07-06 | 2016-07-07 | 1,066,666 | — | $0 | 1,279,999 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | C Conversion | 2016-07-06 | 2016-07-07 | 266,666 | — | $0 | 319,999 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | C Conversion | 2016-07-06 | 2016-07-07 | 1,600,000 | — | $0 | 2,879,999 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | C Conversion | 2016-07-06 | 2016-07-07 | 400,000 | — | $0 | 719,999 | SEC↗ |
| MCRB Seres Therapeutics, Inc. | J Other | 2016-05-25 | 2016-05-27 | 800,000 | — | $0 | 8,022,420 | SEC↗ |
| MCRB Seres Therapeutics, Inc. | S Sale | 2016-05-25 | 2016-05-27 | 599,297 | $27.60 | $16.54M | 0 | SEC↗ |
| MCRB Seres Therapeutics, Inc. | S Sale | 2016-05-25 | 2016-05-27 | 80,141 | $27.60 | $2.21M | 1,925,462 | SEC↗ |
| MCRB Seres Therapeutics, Inc. | S Sale | 2016-05-25 | 2016-05-27 | 320,562 | $27.60 | $8.85M | 2,734,994 | SEC↗ |
| MCRB Seres Therapeutics, Inc. | J Other | 2016-05-25 | 2016-05-27 | 33,514 | — | $0 | 0 | SEC↗ |
| MCRB Seres Therapeutics, Inc. | J Other | 2016-05-25 | 2016-05-27 | 7 | — | $0 | 33,514 | SEC↗ |
| MCRB Seres Therapeutics, Inc. | J Other | 2016-05-25 | 2016-05-27 | 33,507 | — | $0 | 33,514 | SEC↗ |
| MCRB Seres Therapeutics, Inc. | J Other | 2016-05-25 | 2016-05-27 | 200,000 | — | $0 | 1,925,462 | SEC↗ |
| EDIT Editas Medicine, Inc. | C Conversion deriv | 2016-02-08 | 2016-02-09 | 199,999 | — | $0 | 0 | SEC↗ |
| EDIT Editas Medicine, Inc. | C Conversion deriv | 2016-02-08 | 2016-02-09 | 1,051,060 | — | $0 | 0 | SEC↗ |
| EDIT Editas Medicine, Inc. | C Conversion deriv | 2016-02-08 | 2016-02-09 | 1,325,708 | — | $0 | 0 | SEC↗ |
| EDIT Editas Medicine, Inc. | C Conversion deriv | 2016-02-08 | 2016-02-09 | 800,001 | — | $0 | 0 | SEC↗ |
| EDIT Editas Medicine, Inc. | C Conversion deriv | 2016-02-08 | 2016-02-09 | 4,204,240 | — | $0 | 0 | SEC↗ |
| EDIT Editas Medicine, Inc. | C Conversion deriv | 2016-02-08 | 2016-02-09 | 5,302,834 | — | $0 | 0 | SEC↗ |
| EDIT Editas Medicine, Inc. | C Conversion | 2016-02-08 | 2016-02-09 | 509,885 | — | $0 | 509,885 | SEC↗ |
| EDIT Editas Medicine, Inc. | C Conversion | 2016-02-08 | 2016-02-09 | 307,692 | — | $0 | 3,964,256 | SEC↗ |
| EDIT Editas Medicine, Inc. | C Conversion | 2016-02-08 | 2016-02-09 | 76,922 | — | $0 | 991,060 | SEC↗ |
| EDIT Editas Medicine, Inc. | C Conversion | 2016-02-08 | 2016-02-09 | 2,039,549 | — | $0 | 2,039,549 | SEC↗ |
| EDIT Editas Medicine, Inc. | C Conversion | 2016-02-08 | 2016-02-09 | 404,253 | — | $0 | 914,138 | SEC↗ |
| EDIT Editas Medicine, Inc. | C Conversion | 2016-02-08 | 2016-02-09 | 1,617,015 | — | $0 | 3,656,564 | SEC↗ |
| MCRB Seres Therapeutics, Inc. | C Conversion deriv | 2015-06-26 | 2015-06-29 | 898,877 | — | $0 | 0 | SEC↗ |
| MCRB Seres Therapeutics, Inc. | C Conversion deriv | 2015-06-26 | 2015-06-29 | 6,105,362 | — | $0 | 0 | SEC↗ |
| MCRB Seres Therapeutics, Inc. | C Conversion deriv | 2015-06-26 | 2015-06-29 | 1,526,338 | — | $0 | 0 | SEC↗ |
| MCRB Seres Therapeutics, Inc. | C Conversion deriv | 2015-06-26 | 2015-06-29 | 454,546 | — | $0 | 0 | SEC↗ |
| MCRB Seres Therapeutics, Inc. | C Conversion deriv | 2015-06-26 | 2015-06-29 | 1,818,181 | — | $0 | 0 | SEC↗ |
| MCRB Seres Therapeutics, Inc. | C Conversion deriv | 2015-06-26 | 2015-06-29 | 224,719 | — | $0 | 0 | SEC↗ |
| MCRB Seres Therapeutics, Inc. | C Conversion deriv | 2015-06-26 | 2015-06-29 | 599,297 | — | $0 | 0 | SEC↗ |
| MCRB Seres Therapeutics, Inc. | C Conversion | 2015-06-26 | 2015-06-29 | 599,297 | — | $0 | 599,297 | SEC↗ |
| MCRB Seres Therapeutics, Inc. | C Conversion | 2015-06-26 | 2015-06-29 | 2,205,603 | — | $0 | 2,205,603 | SEC↗ |
| MCRB Seres Therapeutics, Inc. | C Conversion | 2015-06-26 | 2015-06-29 | 8,822,420 | — | $0 | 8,822,420 | SEC↗ |
| MCRB Seres Therapeutics, Inc. | A Award deriv | 2015-06-25 | 2015-06-29 | 15,000 | — | $0 | 15,000 | SEC↗ |
| EBIO Eleven Biotherapeutics, In | C Conversion deriv | 2014-02-11 | 2014-02-13 | 1,050,000 | — | $0 | 0 | SEC↗ |
| EBIO Eleven Biotherapeutics, In | C Conversion deriv | 2014-02-11 | 2014-02-13 | 1,680,213 | — | $0 | 0 | SEC↗ |
| EBIO Eleven Biotherapeutics, In | C Conversion deriv | 2014-02-11 | 2014-02-13 | 420,053 | — | $0 | 0 | SEC↗ |
| EBIO Eleven Biotherapeutics, In | C Conversion deriv | 2014-02-11 | 2014-02-13 | 4,200,000 | — | $0 | 0 | SEC↗ |
| EBIO Eleven Biotherapeutics, In | C Conversion deriv | 2014-02-11 | 2014-02-13 | 9,000,000 | — | $0 | 0 | SEC↗ |
| EBIO Eleven Biotherapeutics, In | C Conversion | 2014-02-11 | 2014-02-13 | 926,017 | — | $0 | 1,041,427 | SEC↗ |
| EBIO Eleven Biotherapeutics, In | C Conversion | 2014-02-11 | 2014-02-13 | 1,417,323 | — | $0 | 1,692,913 | SEC↗ |
| EBIO Eleven Biotherapeutics, In | C Conversion | 2014-02-11 | 2014-02-13 | 231,504 | — | $0 | 260,356 | SEC↗ |
| EBIO Eleven Biotherapeutics, In | P Buy | 2014-02-11 | 2014-02-13 | 32,912 | $10.00 | $329.1K | 293,268 | SEC↗ |
| EBIO Eleven Biotherapeutics, In | P Buy | 2014-02-11 | 2014-02-13 | 214,095 | $10.00 | $2.14M | 1,907,008 | SEC↗ |
| EBIO Eleven Biotherapeutics, In | P Buy | 2014-02-11 | 2014-02-13 | 131,722 | $10.00 | $1.32M | 1,173,149 | SEC↗ |